Emerald Advisers, LLC Neogenomics Inc Transaction History
Emerald Advisers, LLC
- $2.01 Billion
- Q1 2025
A detailed history of Emerald Advisers, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Emerald Advisers, LLC holds 855,688 shares of NEO stock, worth $6.1 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
855,688
Previous 1,557,437
45.06%
Holding current value
$6.1 Million
Previous $25.7 Million
68.36%
% of portfolio
0.4%
Previous 1.09%
Shares
31 transactions
Others Institutions Holding NEO
# of Institutions
288Shares Held
127MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$140 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$102 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$47.9 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$43.1 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$40.9 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $897M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...